Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
2023 Standout
Challenges and opportunities in NASH drug development
2023 Standout
Works of Kazuo Inui being referenced
Efficacy of rosuvastatin for the treatment of non‐alcoholic steatohepatitis with dyslipidemia: An open‐label, pilot study
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kazuo Inui | 1849 | 823 | 795 | 105 | 2.3k | |
| Basile Njei | 1774 | 1171 | 768 | 117 | 3.0k | |
| Mark Wilkinson | 1108 | 951 | 587 | 74 | 2.1k | |
| Kensuke Kubota | 2134 | 978 | 945 | 185 | 3.9k | |
| Noritoshi Kobayashi | 1038 | 489 | 936 | 155 | 2.7k | |
| Naotaka Fujita | 3760 | 2693 | 2243 | 224 | 4.5k | |
| W. Van Steenbergen | 1074 | 609 | 580 | 98 | 2.1k | |
| Akihiro Yamaguchi | 879 | 562 | 771 | 147 | 2.4k | |
| Hans Fromm | 1019 | 646 | 894 | 116 | 2.5k | |
| Jimin Han | 1215 | 875 | 638 | 115 | 1.7k | |
| Michael P. Vezeridis | 1204 | 599 | 1291 | 75 | 2.9k |
All Works
Loading papers...